This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?
A national survey of participant outcomes is important for documenting how the CDSMP program is impacting people with chronic diseases and influencing health care outcomes. This study will help bridge the research to practice gap and further our knowledge about the outcomes of evidence?based programs that are widely disseminated. Investigators hope to learn the answers to the following questions for English and Spanish-speaking populations: 1. How does the CDSMP impact a person's general health? 2. Does the CDSMP increase the use of healthful behaviors? 3. Does the CDSMP impact health care utilization? 4. What are the characteristics of those who benefit from the CDSMP? 5. Can these benefits be maintained over 6 and 12 month periods? 6. For people with type 2 diabetes, and hemoglobin A1c be impacted by the CDSMP?
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
1,170
6 week, small group self-management workshop
Stanford University School of Medicine
Stanford, California, United States
Change in Health Status (symptoms, activities limitations)
Time frame: Baseline to 6 months
Change in Health Status (symptoms, activities limitations)
Time frame: baseline to 12 months
Change in Health behaviors (exercise, medical adherence)
Time frame: baseline to 6 months
Change in health related quality of life
Time frame: baseline to 6 months
Change in Metabolic control (HbA1c for type 2 diabetics)
Time frame: baseline to 6 months
Change in Health Care Utilization
MD, emergency, hospital times and total nights
Time frame: baseline to 6 months
Change in Health behaviors (exercise, medical adherence)
Time frame: baseline to 12 months
Change in health related quality of life
Time frame: baseline to 12 months
Change in Metabolic control (HbA1c for type 2 diabetics)
Time frame: baseline to 12 months
Change in Health Care Utilization
Time frame: baseline to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.